Renal Cancer - Results from #4220

An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours September 20, 2018

Exelixis’ Partner Ipsen Announces Health Canada’s Approval of Cabozantinib Tablets for the Treatment of Adults with Previously Treated Advanced Renal Cell Carcinoma September 19, 2018

Value of Contrast-Enhanced Ultrasound in the Diagnosis of Renal Cancer and in Comparison With Contrast-Enhanced Computed Tomography: A Meta-analysis September 19, 2018

Estimated GFR and Hospital-Acquired Infections Following Major Surgery September 19, 2018

Global and targeted microRNA expression profiling in clear cell renal cell carcinoma tissues potentially links miR-155-5p and miR-210-3p to both tumorigenesis and recurrence September 19, 2018

Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma September 19, 2018

Partial Nephrectomy Is Not Associated With an Overall Survival Advantage Over Radical Nephrectomy in Elderly Patients With Stage I and II Renal Masses: An Analysis of the National Cancer Database September 18, 2018

Aging phenotype(s) in kidneys of diabetic mice are p66ShcA dependent September 18, 2018

The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy September 18, 2018

Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program September 18, 2018

Efficacy of Axitinib as Second-line Treatment in Locally Advanced and Metastatic Renal Cell Carcinoma September 17, 2018

The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma September 17, 2018

An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma September 17, 2018

A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis. September 14, 2018

Circulating Tumor Cells for the Management of Renal Cell Carcinoma September 14, 2018

Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma September 14, 2018

Trends and Patient Characteristics Associated with Tobacco Pharmacotherapy Dispensed in the Veterans Health Administration September 13, 2018

Treating patients with renal cell carcinoma and bone metastases September 13, 2018

Role of Stereotactic body radiation therapy in the management of oligometastatic renal cell carcinoma September 13, 2018

Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma September 12, 2018

Page 212 of 456